
James McCarty, MD
Advertisement
Articles by James McCarty, MD

Advertisement
Latest Updated Articles
Therapeutic Pathways for Antimicrobial Use: Pediatric IssuesOctober 1st 1998
Advertisement
Advertisement
Trending on AJMC
1
Medicare Part D Ruxolitinib Spending Hits $49.6 Million as Use Surges
2
Surrogate End Points, Drug Costs Complicate Oncology Formularies
3
Peptide Regulation Debate Intensifies After FDA Advisory Panel's Controversial Vote
4
Perceptions About CGMs Among Primary Care Physicians and Endocrinologists
5